Avenue Biosciences raised a $5.7M seed extension co-led by Balnord and Tesi, joined by Voima Ventures, Inventure, University of Helsinki, and Dimerent.
02 January 2026
02 January 2026
Total investments received (USD): 8.2M
Round value (USD): 5.7M
Company: Avenue Biosciences
Related deals
Vexlum raises €6 million in a seed round led by Kvanted, with participation from Finnish state-owned Tesi (Finnish Industry Investment) and the EIC Fund
Investments
14 January 2026
Qli5 Therapeutics raises €6.2M with Qurient Therapeutic, Robert Huber
Investments
11 January 2026
NuVision raises £4.8M in an equity round led by Mercia Ventures, University of Nottingham and Pioneer in the UK
Investments
06 January 2026
Gardia raised €8.5m series A led by Peak Capital, joined by Amberra, Bonventure, Dieter von Holtzbrinck Ventures, and Beurer.
Investments
05 January 2026
Sparxell raised $5m in a seed extension led by Swen Capital Partners, joined by Alpha Star Capital and Cambridge Enterprise
Investments
03 January 2026
Austria
Switzerland
Denmark
Estonia
Iceland
Latvia
Lithuania
Norway
Sweden
Ireland
Italy
Portugal
Spain